SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
+0.8%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$1.42M
AUM Growth
+$1.42M
(+65%)
Cap. Flow
+$1.17M
Cap. Flow
% of AUM
82.19%
Top 10 Holdings %
Top 10 Hldgs %
85.81%
Holding
200
New
33
Increased
31
Reduced
36
Closed
37
Top Buys
| 1 |
Pfizer
PFE
|
$39.1K |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$27.4K |
| 3 |
Merck
MRK
|
$12K |
| 4 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$11.6K |
| 5 |
Gilead Sciences
GILD
|
$10.7K |
Top Sells
| 1 |
Acadia Healthcare
ACHC
|
$16.4K |
| 2 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$9.99K |
| 3 |
Tesla
TSLA
|
$7.93K |
| 4 |
Larimar Therapeutics
LRMR
|
$6.67K |
| 5 |
Ocular Therapeutix
OCUL
|
$4.66K |
Sector Composition
| 1 | Healthcare | 20.45% |
| 2 | Energy | 0.93% |
| 3 | Industrials | 0.31% |
| 4 | Consumer Staples | 0.23% |
| 5 | Technology | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
APEN
26
DELISTED
Apollo Endosurgery, Inc.
APEN
| $3.52K | 0.11% |
1,248,097
-380,003
| -23% | -$1.07K |
|
27
Abeona Therapeutics
ABEO
$353M
| $3.47K | 0.11% |
+990,595
| New | +$3.47K |
|
|
28
Larimar Therapeutics
LRMR
$330M
| $3.43K | 0.11% |
111,259
-216,307
| -66% | -$6.67K |
|
|
RIBT
29
DELISTED
RiceBran Technologies
RIBT
| $3.33K | 0.11% |
+799,200
| New | +$3.33K |
|
30
Keysight
KEYS
$28.3B
| $2.84K | 0.09% |
+83,978
| New | +$2.84K |
|
31
Rockwell Medical
RMTI
$58.2M
| $2.83K | 0.09% |
275,000
+63,365
| +30% | +$651 |
|
|
RPRX
32
DELISTED
Repros Therapeutics Inc.
RPRX
| $2.79K | 0.09% |
279,879
-15,742
| -5% | -$157 |
|
|
OCRX
33
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $2.74K | 0.09% |
+429,945
| New | +$2.74K |
|
|
ASPX
34
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $2.62K | 0.08% |
50,000
-70,000
| -58% | -$3.67K |
|
|
AKTX
35
Akari Therapeutics
AKTX
$22M
| $2.59K | 0.08% |
538,703
-321,750
| -37% | -$1.54K |
|
|
TTOO
36
DELISTED
T2 Biosystems, Inc
TTOO
| $2.57K | 0.08% |
133,809
+28,442
| +27% | +$547 |
|
37
MEI Pharma
MEIP
$149M
| $2.56K | 0.08% |
600,000
+336,277
| +128% | +$1.44K |
|
38
TherapeuticsMD
TXMD
$12.7M
| $2.45K | 0.08% |
+549,864
| New | +$2.45K |
|
|
DRNA
39
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.4K | 0.08% |
145,919
-114,081
| -44% | -$1.88K |
|
40
Trupanion
TRUP
$1.92B
| $2.39K | 0.08% |
345,205
+110,205
| +47% | +$764 |
|
|
41
Ocular Therapeutix
OCUL
$2.21B
| $2.33K | 0.07% |
98,951
-198,156
| -67% | -$4.66K |
|
42
Community Health Systems
CYH
$394M
| $2.32K | 0.07% |
+43,027
| New | +$2.32K |
|
|
CRDC
43
DELISTED
CARDICA INC COM NEW (DE)
CRDC
| $2.2K | 0.07% |
3,146,657
+2,127,520
| +209% | +$1.49K |
|
|
SCTL
44
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $2.2K | 0.07% |
767,836
+490,334
| +177% | +$1.4K |
|
|
ALBO
45
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $2.15K | 0.07% |
1,615,143
+122,340
| +8% | +$163 |
|
|
RXDX
46
DELISTED
Ignyta, Inc.
RXDX
| $2.13K | 0.07% |
311,191
+81,490
| +35% | +$558 |
|
47
Amicus Therapeutics
FOLD
$2.42B
| $2.05K | 0.06% |
+246,697
| New | +$2.05K |
|
|
SHPG
48
DELISTED
Shire pic
SHPG
| $2.05K | 0.06% |
9,652
-303
| -3% | -$64 |
|
49
Savara
SVRA
$588M
| $1.98K | 0.06% |
+3,539,779
| New | +$1.98K |
|
50
InspireMD
NSPR
$101M
| $1.96K | 0.06% |
+2,517,334
| New | +$1.96K |
|